Creative Other Liab vs Short Long Term Debt Total Analysis

CELZ Stock

USD 2.67 0.02 0.75%

Creative Medical financial indicator trend analysis is way more than just evaluating Creative Medical Tec prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Creative Medical Tec is a good investment. Please check the relationship between Creative Medical Other Liab and its Short Long Term Debt Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Other Liab vs Short Long Term Debt Total

Other Liab vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Creative Medical Tec Other Liab account and Short Long Term Debt Total. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Creative Medical's Other Liab and Short Long Term Debt Total is 0.44. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Creative Medical Technology, assuming nothing else is changed. The correlation between historical values of Creative Medical's Other Liab and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Creative Medical Technology are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Other Liab i.e., Creative Medical's Other Liab and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.44

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Liab

Short Long Term Debt Total

Most indicators from Creative Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Creative Medical Tec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Creative Medical's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 3.2 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2020	2021	2023	2024 (projected)
Reconciled Depreciation	66.8K	92.1K	105.9K	64.0K
Depreciation And Amortization	66.8K	92.1K	94.6K	57.6K

Reconciled Depreciation Depreciation And Amortization

Creative Medical fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Debt	Cash	Cash And Short Term Investments	Other Current Assets	Short Long Term Debt Total	Short Term Debt	Other Current Liab	Current Deferred Revenue	Net Tangible Assets	Other Liab	Non Current Assets Total	Long Term Debt	Short Long Term Debt	Intangible Assets
Total Assets		-0.12	0.59	-0.75	0.8	-0.86	0.85	0.62	0.93	-0.12	1.0	-0.24	-0.91	0.89	1.0	0.86	-0.4	-0.39	-0.17	-0.2	0.62	0.53	0.61	-0.56	0.56	0.61
Total Current Liabilities	-0.12		-0.87	-0.47	0.05	0.13	-0.14	0.32	0.02	1.0	-0.14	0.66	0.13	-0.09	-0.14	-0.14	0.61	0.61	1.0	0.83	-0.83	0.37	0.59	-0.37	0.39	0.59
Total Stockholder Equity	0.59	-0.87		0.01	0.35	-0.53	0.53	0.04	0.44	-0.87	0.61	-0.65	-0.55	0.51	0.61	0.53	-0.69	-0.69	-0.9	-0.77	0.98	-0.04	-0.18	0.03	-0.05	-0.18
Retained Earnings	-0.75	-0.47	0.01		-0.52	0.7	-0.75	-0.52	-0.89	-0.47	-0.73	-0.21	0.55	-0.55	-0.73	-0.69	-0.08	-0.09	-0.43	-0.33	-0.09	-0.77	-0.93	0.8	-0.83	-0.93
Accounts Payable	0.8	0.05	0.35	-0.52		-0.63	0.49	0.9	0.61	0.05	0.81	-0.05	-0.91	0.93	0.81	0.65	-0.13	-0.13	-0.03	-0.02	0.31	0.45	0.46	-0.46	0.45	0.45
Net Receivables	-0.86	0.13	-0.53	0.7	-0.63		-0.97	-0.42	-0.87	0.13	-0.86	0.23	0.64	-0.6	-0.86	-1.0	0.37	0.36	0.17	0.19	-0.62	-0.44	-0.45	0.47	-0.47	-0.45
Common Stock Shares Outstanding	0.85	-0.14	0.53	-0.75	0.49	-0.97		0.28	0.92	-0.14	0.85	-0.24	-0.57	0.53	0.85	0.96	-0.39	-0.38	-0.16	-0.19	0.64	0.47	0.52	-0.52	0.51	0.52
Non Current Liabilities Total	0.62	0.32	0.04	-0.52	0.9	-0.42	0.28		0.47	0.32	0.61	0.02	-0.75	0.79	0.61	0.44	0.17	0.17	0.24	0.27	-0.01	0.45	0.58	-0.45	0.53	0.58
Other Stockholder Equity	0.93	0.02	0.44	-0.89	0.61	-0.87	0.92	0.47		0.02	0.93	-0.12	-0.73	0.7	0.92	0.87	-0.24	-0.23	-0.02	-0.05	0.53	0.66	0.75	-0.7	0.71	0.75
Total Liab	-0.12	1.0	-0.87	-0.47	0.05	0.13	-0.14	0.32	0.02		-0.14	0.66	0.13	-0.09	-0.14	-0.14	0.61	0.61	1.0	0.83	-0.83	0.37	0.58	-0.37	0.39	0.59
Total Current Assets	1.0	-0.14	0.61	-0.73	0.81	-0.86	0.85	0.61	0.93	-0.14		-0.25	-0.92	0.89	1.0	0.87	-0.42	-0.41	-0.2	-0.22	0.64	0.51	0.59	-0.54	0.54	0.59
Common Stock	-0.24	0.66	-0.65	-0.21	-0.05	0.23	-0.24	0.02	-0.12	0.66	-0.25		0.23	-0.19	-0.25	-0.23	0.6	0.6	0.65	0.47	-0.64	0.36	0.2	-0.36	0.27	0.2
Net Debt	-0.91	0.13	-0.55	0.55	-0.91	0.64	-0.57	-0.75	-0.73	0.13	-0.92	0.23		-1.0	-0.92	-0.65	0.4	0.39	0.19	0.23	-0.51	-0.4	-0.48	0.41	-0.4	-0.48
Cash	0.89	-0.09	0.51	-0.55	0.93	-0.6	0.53	0.79	0.7	-0.09	0.89	-0.19	-1.0		0.9	0.61	-0.33	-0.33	-0.15	-0.17	0.46	0.43	0.5	-0.43	0.43	0.5
Cash And Short Term Investments	1.0	-0.14	0.61	-0.73	0.81	-0.86	0.85	0.61	0.92	-0.14	1.0	-0.25	-0.92	0.9		0.86	-0.42	-0.41	-0.2	-0.22	0.64	0.51	0.59	-0.54	0.54	0.59
Other Current Assets	0.86	-0.14	0.53	-0.69	0.65	-1.0	0.96	0.44	0.87	-0.14	0.87	-0.23	-0.65	0.61	0.86		-0.37	-0.37	-0.18	-0.2	0.62	0.43	0.45	-0.46	0.46	0.44
Short Long Term Debt Total	-0.4	0.61	-0.69	-0.08	-0.13	0.37	-0.39	0.17	-0.24	0.61	-0.42	0.6	0.4	-0.33	-0.42	-0.37		1.0	0.59	0.8	-0.69	0.44	0.28	-0.43	0.47	0.29
Short Term Debt	-0.39	0.61	-0.69	-0.09	-0.13	0.36	-0.38	0.17	-0.23	0.61	-0.41	0.6	0.39	-0.33	-0.41	-0.37	1.0		0.59	0.8	-0.69	0.45	0.29	-0.44	0.48	0.29
Other Current Liab	-0.17	1.0	-0.9	-0.43	-0.03	0.17	-0.16	0.24	-0.02	1.0	-0.2	0.65	0.19	-0.15	-0.2	-0.18	0.59	0.59		0.81	-0.85	0.32	0.55	-0.32	0.34	0.55
Current Deferred Revenue	-0.2	0.83	-0.77	-0.33	-0.02	0.19	-0.19	0.27	-0.05	0.83	-0.22	0.47	0.23	-0.17	-0.22	-0.2	0.8	0.8	0.81		-0.74	0.51	0.53	-0.51	0.5	0.53
Net Tangible Assets	0.62	-0.83	0.98	-0.09	0.31	-0.62	0.64	-0.01	0.53	-0.83	0.64	-0.64	-0.51	0.46	0.64	0.62	-0.69	-0.69	-0.85	-0.74		0.01	-0.11	-0.03	0.02	-0.11
Other Liab	0.53	0.37	-0.04	-0.77	0.45	-0.44	0.47	0.45	0.66	0.37	0.51	0.36	-0.4	0.43	0.51	0.43	0.44	0.45	0.32	0.51	0.01		0.8	-0.97	0.95	0.8
Non Current Assets Total	0.61	0.59	-0.18	-0.93	0.46	-0.45	0.52	0.58	0.75	0.58	0.59	0.2	-0.48	0.5	0.59	0.45	0.28	0.29	0.55	0.53	-0.11	0.8		-0.81	0.88	1.0
Long Term Debt	-0.56	-0.37	0.03	0.8	-0.46	0.47	-0.52	-0.45	-0.7	-0.37	-0.54	-0.36	0.41	-0.43	-0.54	-0.46	-0.43	-0.44	-0.32	-0.51	-0.03	-0.97	-0.81		-0.95	-0.81
Short Long Term Debt	0.56	0.39	-0.05	-0.83	0.45	-0.47	0.51	0.53	0.71	0.39	0.54	0.27	-0.4	0.43	0.54	0.46	0.47	0.48	0.34	0.5	0.02	0.95	0.88	-0.95		0.88
Intangible Assets	0.61	0.59	-0.18	-0.93	0.45	-0.45	0.52	0.58	0.75	0.59	0.59	0.2	-0.48	0.5	0.59	0.44	0.29	0.29	0.55	0.53	-0.11	0.8	1.0	-0.81	0.88

Click cells to compare fundamentals

Creative Medical Account Relationship Matchups

Creative Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	530.8K	717.8K	11.3M	19.2M	10.7M	11.3M
Total Current Liabilities	8.6M	40.5M	1.1M	3.3M	371.4K	352.8K
Total Stockholder Equity	(8.1M)	(39.8M)	10.2M	15.9M	10.3M	10.9M
Retained Earnings	(25.6M)	(61.9M)	(43.7M)	(53.8M)	(59.1M)	(56.1M)
Accounts Payable	320.8K	350.9K	761.9K	3.3M	317.3K	370.6K
Net Receivables	5.6K	0.0	2.5K	(10.1M)	(9.1M)	(8.6M)
Common Stock Shares Outstanding	2.1K	57.9K	324.9K	1.1M	1.4M	1.5M
Liabilities And Stockholders Equity	530.8K	717.8K	11.3M	19.2M	10.7M	11.3M
Non Current Liabilities Total	4.1K	0.0	1.4M	1.1M	761.9K	3.3M
Other Stockholder Equity	17.5M	21.3M	53.9M	69.7M	69.4M	72.9M
Total Liab	8.6M	40.5M	1.1M	3.3M	371.4K	352.8K
Total Current Assets	94.2K	98.0K	10.7M	18.7M	10.3M	10.8M
Common Stock	22.5K	768.5K	6.3K	14.1K	1.4K	1.4K
Net Debt	973.6K	690.7K	(10.7M)	(18.4M)	(3.5M)	(3.3M)
Cash	88.6K	98.0K	10.7M	18.4M	3.5M	2.2M
Cash And Short Term Investments	88.6K	98.0K	10.7M	18.4M	10.0M	10.5M
Short Long Term Debt Total	682.1K	1.1M	788.7K	14.2K	16.3K	15.5K
Short Term Debt	682.1K	1.1M	788.7K	14.2K	16.3K	15.5K
Other Current Liab	6.8M	39.4M	288.6K	54.1K	62.2K	59.1K
Current Deferred Revenue	10.8K	371.4K	639.4K	(14.2K)	(16.3K)	(15.5K)
Net Tangible Assets	(8.5M)	(40.4M)	9.7M	15.4M	17.7M	18.6M
Non Current Assets Total	436.6K	619.8K	531.0K	438.9K	444.3K	401.4K
Non Currrent Assets Other	163.5K	(436.6K)	(619.8K)	3.3K	3.0K	3.1K
Short Long Term Debt	512.5K	682.1K	1.1M	788.7K	907.0K	692.0K
Intangible Assets	436.6K	619.8K	527.7K	435.6K	441.0K	400.0K
Net Invested Capital	(7.0M)	(39.0M)	10.2M	15.9M	10.3M	10.9M
Net Working Capital	(8.5M)	(40.4M)	9.7M	15.4M	9.9M	10.4M
Capital Stock	25.5K	771.5K	6.3K	14.1K	1.4K	1.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Creative Other Liab vs Short Long Term Debt Total Analysis

Other Liab vs Short Long Term Debt Total

Other Liab vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Other Liab

Short Long Term Debt Total

Creative Medical fundamental ratios Correlations

Creative Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Creative Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for Creative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Other Current Liab	+ 1.0	Total Current Liabilities
Other Current Liab	+ 1.0	Total Liab
Cash And Short Term Investments	+ 1.0	Total Current Assets

Cash	- 1.0	Net Debt
Other Current Assets	- 1.0	Net Receivables
Long Term Debt	- 0.97	Other Liab
Common Stock Shares Outstanding	- 0.97	Net Receivables
Short Long Term Debt	- 0.95	Long Term Debt
Intangible Assets	- 0.93	Retained Earnings